User contributions
From WikiPathways
(Latest | Earliest) View (newer 20) (older 20) (20 | 50 | 100 | 250 | 500)
- 21:11, 16 March 2022 Help:LiteratureReferences (updated message)
- 19:12, 23 December 2021 WP5078 (Discussion edited) (top)
- 19:12, 23 December 2021 N WP5078 (Talkpage autocreated when first thread was posted.)
- 19:12, 23 December 2021 N What's the status on this pathway? (1) (created post) (top)
- 18:47, 23 December 2021 TheodorosZarotiadis (Discussion edited) (top)
- 18:47, 23 December 2021 N Thanks for starting a new pathway! (4) (Thanks for starting a new pathway!) (top)
- 18:35, 23 December 2021 Mus musculus:Oxylipins pathways (Ontology Term : 'fatty acid biosynthetic pathway' added !)
- 18:27, 23 December 2021 Lcayer (Discussion edited) (top)
- 18:27, 23 December 2021 N Thanks for starting a new pathway! (3) (Thanks for starting a new pathway!) (top)
- 19:32, 8 December 2021 N Raised Toilet Seats (2) (Thread:Raised Toilet Seats (2) moved to Deleted 2) (top)
- 19:29, 8 December 2021 N Raised Toilet Seats (1) (Thread:Raised Toilet Seats (1) moved to Deleted) (top)
- 19:29, 8 December 2021 m Deleted (Thread:Raised Toilet Seats (1) moved to Deleted) (top)
- 19:47, 5 November 2021 Authors
- 06:33, 20 June 2021 Homo sapiens:Familial partial lipodystrophy (Not mim-conversion's)
- 06:28, 20 June 2021 Homo sapiens:Progeria-associated lipodystrophy (Not mim-conversion's) (top)
- 12:17, 18 June 2021 Funding and Support (→Content contributions partly funded by)
- 06:03, 27 February 2021 Homo sapiens:FOXP3 in COVID-19 (Ontology Term : 'severe acute respiratory syndrome' added !)
- 06:02, 27 February 2021 Homo sapiens:FOXP3 in COVID-19 (Ontology Term : 'disease pathway' added !)
- 06:44, 5 February 2021 Homo sapiens:SARS-CoV-2 innate immunity evasion and cell-specific immune response (Replaced tow DOIs with the matching PubMed IDs)
- 09:43, 29 January 2021 Homo sapiens:SARS-CoV-2 innate immunity evasion and cell-specific immune response (Replaced another DOI with its corresponding PubMed identifier)
(Latest | Earliest) View (newer 20) (older 20) (20 | 50 | 100 | 250 | 500)